Tao Zhu

Affiliations: 
School of Life Science, University of Sciences and Technology of China, Hefei Shi, Anhui Sheng, China 
Google:
"Tao Zhu"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Yang L, Wang M, Wang Y, et al. (2024) LINC00460-FUS-MYC feedback loop drives breast cancer metastasis and doxorubicin resistance. Oncogene
Zhang X, Pandey V, Bhardwaj V, et al. (2023) Autocrine/paracrine growth hormone in cancer progression. Endocrine-Related Cancer
Li L, Lv L, Xu JC, et al. (2023) RIG-I Promotes Tumorigenesis and Confers Radioresistance of Esophageal Squamous Cell Carcinoma by Regulating DUSP6. International Journal of Molecular Sciences. 24
Wu M, Zhang X, Zhang W, et al. (2023) Paracrine secretion of IL8 by breast cancer stem cells promotes therapeutic resistance and metastasis of the bulk tumor cells. Cell Communication and Signaling : Ccs. 21: 59
Pandey V, Zhang X, Poh HM, et al. (2022) Monomerization of Homodimeric Trefoil Factor 3 (TFF3) by an Aminonitrile Compound Inhibits TFF3-Dependent Cancer Cell Survival. Acs Pharmacology & Translational Science. 5: 761-773
Cheng F, Wang X, Chiou YS, et al. (2022) Trefoil factor 3 promotes pancreatic carcinoma progression via WNT pathway activation mediated by enhanced WNT ligand expression. Cell Death & Disease. 13: 265
Wu M, Zhang X, Zhang W, et al. (2022) Cancer stem cell regulated phenotypic plasticity protects metastasized cancer cells from ferroptosis. Nature Communications. 13: 1371
Zhuang QS, Sun XB, Chong QY, et al. (2021) ARTEMIN Promotes Oncogenicity and Resistance to 5-Fluorouracil in Colorectal Carcinoma by p44/42 MAPK Dependent Expression of CDH2. Frontiers in Oncology. 11: 712348
Zhu T, Zheng J, Zhuo W, et al. (2021) ETV4 promotes breast cancer cell stemness by activating glycolysis and CXCR4-mediated sonic Hedgehog signaling. Cell Death Discovery. 7: 126
Wang X, Guo Q, Wang H, et al. (2020) PCBP2 post-transcriptional modifications induce breast cancer progression via upregulation of UFD1 and NT5E. Molecular Cancer Research : McR
See more...